Abstract: A secondary battery cell includes an anode electrode plate, an anode electrode tab, a cathode electrode plate, a cathode electrode tab and a separator. The secondary battery cell winding formation system includes a working platform, a winding mechanism, an anode electrode plate unwinding roller, an anode electrode plate cleaning mechanism, an anode electrode plate die-cutting mechanism, an anode electrode tab supply mechanism, an anode electrode tab connection mechanism, an anode electrode plate convey mechanism, a cathode electrode plate unwinding roller, a cathode electrode plate cleaning mechanism, a cathode electrode plate die-cutting mechanism, a cathode electrode tab supply mechanism a cathode electrode tab connection mechanism, a cathode electrode plate convey mechanism, a first separator unwinding roller, a second separator unwinding roller, a first separator convey mechanism and a second separator convey mechanism.

Abstract: A sleep-regulating tablet allowing release by stages and a preparation method thereof are provided. The tablet structurally consists of a drug-containing delayed-release tablet core, a drug-free stomach-soluble coating, a drug-free enteric coating, a drug-containing immediate-release shell, and a shell stomach-soluble coating sequentially from inside to outside. An ideal dual-stage timed drug release mode may be realized, and is especially suitable for a sleep-regulating drug, such as ramelteon.

Abstract: An information interaction method and apparatus, an electronic device and a storage medium are provided, the method comprising: displaying a preset first special effect element in a virtual reality space; determining whether a spatial relationship between a target control part controlled by a user and displayed in the virtual reality space and the first special effect element meets a preset condition; and in response to determining that the preset condition is met, displaying a second special effect associated with the first special effect element.

Abstract: Provided are a preparation method for a tumor-infiltrating lymphocyte, and use thereof, particularly relating to a method for culturing a tumor-infiltrating lymphocyte, comprising: subjecting a TIL, which is derived from tumor tissues and not expanded in vitro, to in vitro expansion of at least one stage, and wherein the TIL is contacted with a CD28 agonist in the in vitro expansion of at least one stage. Further provided is a method for preventing and/or treating tumors by using the tumor-infiltrating lymphocyte.

Abstract: A method for culturing tumor infiltrating lymphocytes (TIL), the method comprising co-culturing the expanded TIL with feeder cells after contacting the TIL with a T cell co-stimulatory molecule and/or a T cell growth factor for a period of time. In addition, further provided is a method for preventing and/or treating tumors by means of using the tumor infiltrating lymphocytes of the present application.

Abstract: A compound represented by formula (I) or a tautomer, optical isomer, deuterated substance, oxynitride, solvate, pharmaceutically acceptable salt or prodrug thereof can be used in preparing a pharmaceutical composition. The compound or the pharmaceutical composition can be used in the preparation a drug for the prevention and/or treatment of cancer, tumors, viral infections, depression, neurological disorders, trauma, age-related cataracts, organ transplant rejection or autoimmune diseases.